Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
10.16
-0.30 (-2.87%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Sionna Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Cash & Equivalents
37.7938.5254.84
Short-Term Investments
109.75-27.77
Cash & Short-Term Investments
147.5438.5282.61
Cash Growth
283.01%-53.37%-
Prepaid Expenses
3.460.691.22
Total Current Assets
150.9939.2183.83
Property, Plant & Equipment
10.311.621.79
Long-Term Investments
20.51--
Other Long-Term Assets
3.961.121.74
Total Assets
185.7551.9587.37
Accounts Payable
1.190.720.56
Accrued Expenses
7.676.597.7
Current Portion of Leases
1.070.73-
Other Current Liabilities
0.49--
Total Current Liabilities
10.428.048.25
Long-Term Leases
8.689.75-
Total Liabilities
19.117.798.25
Common Stock
0.0100
Additional Paid-In Capital
174.522.23
Retained Earnings
-181.09-119.4-72.14
Comprehensive Income & Other
0.37--0.02
Total Common Equity
-163.71-114.88-69.92
Shareholders' Equity
166.6634.1679.12
Total Liabilities & Equity
185.7551.9587.37
Total Debt
9.7510.48-
Net Cash (Debt)
158.2928.0482.61
Net Cash Growth
464.45%-66.05%-
Net Cash Per Share
41.029.5632.05
Filing Date Shares Outstanding
44.123.052.58
Total Common Shares Outstanding
4.723.052.58
Working Capital
140.5731.1775.58
Book Value Per Share
-34.66-37.66-27.13
Tangible Book Value
-163.71-114.88-69.92
Tangible Book Value Per Share
-34.66-37.66-27.13
Machinery
2.182.050.62
Construction In Progress
--1.52
Leasehold Improvements
1.851.85-
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q